What is NDC 68475-008?

68475-008 is the product NDC for Maraviroc, Maraviroc 150 mg/1 tablet, film coated, listed with the FDA by Navinta LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Navinta LLC, NDC labeler code 68475. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Maraviroc?

15 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Maraviroc NDC 68475-008 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68475-008Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68475-0008Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68475-008-01	6847500080168475000801	60 TABLET, FILM COATED in 1 BOTTLE (68475-008-01)Marketed from Jun 23, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Maraviroc
Generic name (nonproprietary): maraviroc
Active ingredients: Maraviroc — 150 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Navinta LLCNDC labeler code 68475
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217880
Marketing start: Jun 23, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Chemokine Co-receptor 5 Antagonists (Mechanism)
Identifiers: Product ID 68475-008_9623d31f-0856-4aca-a288-c542b28edfbaSPL ID 9623d31f-0856-4aca-a288-c542b28edfbaSPL set ID 211290a4-5e26-4784-aa99-8ccaf2eaaa15RxCUI 728223, 728225UNII MD6P741W8AUPC 0368475007017, 0368475008014
Pharmacologic class: CCR5 Co-receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468475000801 followed by a unit qualifier and the quantity

Package 68475-0008-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Maraviroc tablets are indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients 2 years of age and older weighing at least 10 kg. Limitations of Use: Maraviroc tablets are not recommended in patients with dual/mixed- or CXCR4-tropic HIV-1 [see Microbiology ( 12.4 )]. Maraviroc tablet is a CCR5 co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. ( 1 ) Limitations of Use: Not recommended in patients with dual…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68475-008

What is NDC 68475-008?: 68475-008 is the product NDC for Maraviroc, Maraviroc 150 mg/1 tablet, film coated, listed with the FDA by Navinta LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Maraviroc.
What is the active ingredient?: Maraviroc.
Who is the labeler?: Navinta LLC, NDC labeler code 68475. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Maraviroc?: 15 other product NDCs are listed under this name. See all Maraviroc NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Maraviroc NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	Rhodes Pharmaceuticals LLC	42858-246	42858-0246-06
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	Rhodes Pharmaceuticals LLC	42858-247	42858-0247-06
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	Navinta LLC	68475-007	68475-0007-01
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1930	70710-1930-06
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1931	70710-1931-06
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	A2A Integrated Pharmaceuticals	73141-024	73141-0024-02
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	A2A Integrated Pharmaceuticals	73141-025	73141-0025-02
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-8010	50090-8010-00
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	i3 Pharmaceuticals, LLC	72319-024	72319-0024-02
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	i3 Pharmaceuticals, LLC	72319-025	72319-0025-02

All 16 Maraviroc NDCs

Other NDCs under ANDA 217880

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217880
Product	Strength	Form · route	Labeler	Product NDC
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	Navinta LLC	68475-007
Maraviroc	Maraviroc 150 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1930
Maraviroc	Maraviroc 300 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals USA Inc.	70710-1931